8-K

Columbia Seligman Premium Technology Growth Fund, Inc. (STK)

8-K 2025-06-24 For: 2025-06-24
View Original
Added on April 12, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 24, 2025

Columbia Seligman Premium Technology Growth Fund, Inc.

(Exact name of registrant as specified in its charter)

MARYLAND 811-22328 20-0994125
(State or other jurisdiction<br> <br>of incorporation) (Commission<br> <br>File Number) (I.R.S. Employer<br> <br>Identification No.)
290 Congress Street, Boston, Massachusetts 02210
--- ---
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (800)-937-5449

NOT APPLICABLE

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock STK The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
--- ---
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

SECTION 7 — REGULATION FD

Item 7.01 Regulation FD Disclosure.

Registrant is furnishing as Exhibit 99.1 the attached Press Release dated June 24, 2025 for Columbia Seligman Premium Technology Growth Fund, Inc.

2

Exhibit Index

Exhibit No. Description
99.1 Press Release
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 24, 2025

COLUMBIA SELIGMAN PREMIUM<br> <br>TECHNOLOGY GROWTH FUND, INC.
By: /s/ Joseph D’Alessandro
Joseph D’Alessandro
Assistant Secretary

4

EX-99.1

Exhibit 99.1

Stockholder contact: salesinquiries@columbiathreadneedle.com
Media contact: Meghan Shields<br><br><br>meghan.shields@columbiathreadneedle.com

COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC.

HOLDS 15^TH^ ANNUAL MEETING OF STOCKHOLDERS

MINNEAPOLIS, MN, June 24, 2025  — Columbia Seligman Premium Technology Growth Fund, Inc. (the “Fund”) (NYSE:STK) today held its 15^th^ Annual Meeting of Stockholders (the “Meeting”) in Minneapolis, Minnesota. Stockholders voted in favor of the recommendations of the Fund’s Board of Directors (the “Board”) on each of two proposals at the Meeting.

Specifically, Stockholders re-elected Directors Daniel J. Beckman, Janet Langford Carrig, Douglas A. Hacker, and Sandra L. Yeager, each for a term that will expire at the Fund’s 2028 Annual Meeting of Stockholders, and all until their successors are elected and qualify. Stockholders also ratified the Board’s selection of PricewaterhouseCoopers LLP as the Fund’s independent registered public accounting firm for the 2025 fiscal year.

The Fund is managed by Columbia Management Investment Advisers, LLC.

Investors should consider the investment objectives, risks, charges, and expenses of the Fund carefully before investing. A prospectus containinginformation about the Fund (including its investment objectives, risks, charges, expenses, and other information about the Fund) may be obtained by contacting your financial advisor or visiting www.columbiathreadneedleus.com. The prospectus shouldbe read carefully before investing in the Fund. For more information, please call 866-666-1532 or visit www.columbiathreadneedleus.com.

The Fund is not insured by the FDIC, NCUA or any federal agency, is not a deposit or obligation of, or guaranteed by any financial institution, and involves investment risks including possible loss of principal and fluctuation in value.

© 2025 Columbia Threadneedle. All rights reserved.

AdTrax CTNA-8096991.1-RUSH